Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.17B P/E - EPS this Y 4.90% Ern Qtrly Grth -
Income -163.43M Forward P/E -42.22 EPS next Y -53.80% 50D Avg Chg 2.00%
Sales 290.7M PEG 1.03 EPS past 5Y 21.67% 200D Avg Chg 13.00%
Dividend N/A Price/Book 0.92 EPS next 5Y -52.25% 52W High Chg -40.00%
Recommedations 2.70 Quick Ratio 4.96 Shares Outstanding 30.30M 52W Low Chg 39.00%
Insider Own 32.01% ROA -3.32% Shares Float 20.13M Beta 1.50
Inst Own 51.79% ROE -14.28% Shares Shorted/Prior 723.21K/699.33K Price 39.26
Gross Margin 39.10% Profit Margin -56.22% Avg. Volume 205,009 Target Price 27.67
Oper. Margin -26.62% Earnings Date Nov 1 Volume 194,782 Change 1.11%
About Fulgent Genetics, Inc.

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

Fulgent Genetics, Inc. News
11/19/24 Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now
11/10/24 Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth
11/10/24 Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations
11/09/24 Fulgent Genetics Reports Strong Q3 2024 Results
11/09/24 Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline
11/08/24 Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates
11/08/24 Fulgent Reports Third Quarter 2024 Financial Results
11/07/24 TruBridge (TBRG) Reports Q3 Loss, Tops Revenue Estimates
11/05/24 Fulgent to Participate in Upcoming Conferences
11/01/24 Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains?
10/31/24 Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1
10/17/24 Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024
10/08/24 Hims & Hers Health (HIMS) Soars 10.1%: Is Further Upside Left in the Stock?
09/18/24 Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 107%
08/13/24 Fulgent Genetics (FLGT) Upgraded to Buy: What Does It Mean for the Stock?
08/13/24 How Much Upside is Left in Fulgent Genetics (FLGT)? Wall Street Analysts Think 27.22%
08/02/24 Fulgent Genetics, Inc. (FLGT) Beats Q2 Earnings and Revenue Estimates
08/02/24 Fulgent Reports Second Quarter 2024 Financial Results
07/18/24 Fulgent Genetics (FLGT) Soars 6.6%: Is Further Upside Left in the Stock?
07/11/24 Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024
FLGT Chatroom

User Image Ernst_Grafenberg Posted - 7 hours ago

$FLGT christ, I forgot just how much this stock sucks. No reason to get battered like this while nearly every other sh*t company just soars on nothing but euphoria. There's nothing fundamental about TDOC or LMND surging by double digits daily. Extremely frustrating.

User Image Endergast07 Posted - 7 hours ago

$FLGT Sexy the only one with puts:

User Image Endergast07 Posted - 7 hours ago

$FLGT Institutions are accumulating

User Image Ernst_Grafenberg Posted - 1 day ago

$FLGT relatively heavy buying in high 16s-low 17s. Maybe, MAYBE, it found a bottom. We'll see. If the market takes a dump, probably another leg down. Ming needs to use some of that cash to buy an AI startup that can boost their diagnostic/clinical biz. The market might jump on that.

User Image jjdoindd Posted - 2 days ago

$FLGT I have to think patient long-term or even medium term value swing traders will be highly rewarded here. I added materially in last couple days and will continue to accumulate. Institutions are on sidelines and not sure value investors even exist anymore. Pretty much momentum players taking this down. Not bleeding too much cash and -$300M EV. Not sure I've seen anything like this. No corporate governance but Ming owns 30% of company so pretty sure incentives are aligned. Just wish he'd start buying back stock. I can see why others wouldn't buy if the company isn't buying at these levels though. Whole stock is bizarre. Nonetheless, easy buy here.

User Image CrayP Posted - 2 days ago

$FLGT I tend to bring out the meme when the options (especially puts) are well below theoretical value. That is, I can't get much of a premium for selling $15 or $17.5 puts, which usually signals odd or unsustainable activity in the equity markets. Oddly, the damage done by piper bringing down the price target to $22 while keeping 2025 revenue estimates the same at $314.6M (up 13% ex-Covid) and raising EBITDA to $17M from $14M while the company will have $28 per share in cash make little sense. Even value traps don't trade at a 40% discount to cash when roughly b-even and turning the corner. Ming discount at all-time high and he is in need of some water torture. Strange days indeed...

User Image Ernst_Grafenberg Posted - 3 days ago

$FLGT a spectacular fall. pretty absurd when you consider how much cash the company has and it's history of operating efficiently. the market is currently interested in a lot of sh*t companies that don't make money and will probably never be profitable

User Image ClarityOfPurpose Posted - 3 days ago

$FLGT Of course I bought some at 16.80. And will buy more if it goes lower. And so on.

User Image CrayP Posted - 3 days ago

$FLGT MMMMMIIIIIIIIINNNNNNGGGGGG!!!!!!

User Image ClarityOfPurpose Posted - 3 days ago

$FLGT A private company masquerading as a public company 😉

User Image Sexydream Posted - 3 days ago

$FLGT 15s before or after Christmas? Heck, at this rate 15s mat come by month end..

User Image ClarityOfPurpose Posted - 3 days ago

$FLGT You have to think that Sheriff Villanueva will probably resurface again as a MAGA acolyte, either in CA or in the Trump admin. Watch out Ming;-)

User Image ClarityOfPurpose Posted - 3 days ago

$FLGT Under normal circumstances, a corporate raider would have come in by now and either insisted on a huge stock buyback, or tried to liquidate the company and pocket the $250M+ residual amount. But the existing Board and stock ownership is packed with insiders just biding their time.

User Image Sexydream Posted - 3 days ago

$FLGT welcome to 16s!! 15 coming before Christmas!!! Flgt, the junky stock that keeps on giving.

User Image ClarityOfPurpose Posted - 6 days ago

$FLGT The one really good thing about their clinical stage playbook is that shorts like SexyDream can’t dilute them and make them go through reverse splits. Sitting on an $800M pile of cash makes a difference in the long run.

User Image ClarityOfPurpose Posted - 6 days ago

$FLGT Ming doesn’t care. He has cheap or free option grants, his Trust’s forward hedge position, and his generous annual compensation. He’s the founder and a major owner and can’t be fired. Ming wins in the end.

User Image Sexydream Posted - 6 days ago

$FLGT 16s by next week. Only fools go long this junk. Still haven't learned by now? You deserve to lose money on this.

User Image theshortsqueezer2022 Posted - 6 days ago

$FLGT drop it to 1$ like $WGS then I’ll buy

User Image ClarityOfPurpose Posted - 6 days ago

$FLGT Paul really wants to buy back more shares - but Ming won’t let him:)

User Image ClarityOfPurpose Posted - 6 days ago

$FLGT Had to buy some here. Just too cheap.

User Image ijod Posted - 1 week ago

$FLGT what ever happened to that CA sheriff?

User Image ClarityOfPurpose Posted - 1 week ago

$FLGT Ming’s Trust kept laddering down and taking more upfront cash as a hedge against a declining stock price. Legal, slick, but ethically dubious imo.

User Image ClarityOfPurpose Posted - 1 week ago

$FLGT Sorry - this is the middle Agreement from June 2022. Done conveniently before rolling the Pharma group back in. https://ir.fulgentgenetics.com/static-files/78d8bd30-c7ee-4dc8-a0a6-5fce8283ee9d

User Image ClarityOfPurpose Posted - 1 week ago

$FLGT And here is the lucrative early Trust agreement from Sep 2021. I wonder if that banker still has a job😉 https://www.sec.gov/Archives/edgar/data/1302110/000120919121055768/xslF345X03/doc4.xml

User Image ClarityOfPurpose Posted - 1 week ago

$FLGT An earlier one: https://ir.fulgentgenetics.com/static-files/2c4d619f-eb23-4035-a898-37081a89377e

User Image ClarityOfPurpose Posted - 1 week ago

$FLGT Read this closely and you will see why CEO Ming is avoiding implementing the significant share buyback. His Trust’s hedge: https://ir.fulgentgenetics.com/static-files/2c4d619f-eb23-4035-a898-37081a89377e

User Image Sexydream Posted - 1 week ago

$FLGT and just like that I made all the money I lost back by shorting this junk again. Lower lows lower highs. Will settle around 16 for now. 5 year target = 0.

User Image ClarityOfPurpose Posted - 1 week ago

$FLGT At least it’s not ‘23andMe’.

User Image Sexydream Posted - 1 week ago

$FLGT sorry been super bz. I sold all my positions for a small loss a few days ago. Glad I did. I maintain my opinion. This stock will do nothing for many years. It'll slowly erode away all the cash it has and over the next 5-10 yrs it'll go to 0. My advice is to short when it goes to 22-23 and cover at 18-19. Rinse and repeat. You will make a lot of money as I have done in the last 2 years.

User Image ClarityOfPurpose Posted - 1 week ago

$FLGT Nice bounce back!

Analyst Ratings
Piper Sandler Neutral Mar 6, 24
UBS Neutral Dec 7, 23
Piper Sandler Neutral Oct 16, 23
Credit Suisse Outperform Mar 2, 23
Piper Sandler Neutral Dec 8, 22
Raymond James Outperform Nov 18, 22
Credit Suisse Outperform Nov 14, 22
Piper Sandler Overweight Nov 14, 22
Credit Suisse Outperform Aug 25, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Xie Jian President and COO President and COO Dec 11 Sell 26.5 22,000 583,000 363,124 12/13/23
Xie Jian President and COO President and COO Dec 04 Sell 27.5732 1,779 49,053 385,124 12/06/23
Kim Paul CFO and Treasurer CFO and Treasurer Dec 04 Sell 27.5732 1,437 39,623 200,460 12/06/23
Gao Hanlin Chief Scientific Off.. Chief Scientific Officer Dec 04 Sell 27.5732 1,437 39,623 905,882 12/06/23
Xie Jian President and COO President and COO Nov 16 Sell 27.2511 1,617 44,065 386,903 11/20/23
Kim Paul CFO and Treasurer CFO and Treasurer Nov 16 Sell 27.2511 1,307 35,617 201,897 11/20/23
Xie Jian President and COO President and COO Sep 07 Sell 31.4079 1,492 46,861 416,022 09/11/23
Kim Paul CFO and Treasurer CFO and Treasurer Sep 07 Sell 31.4079 1,492 46,861 214,061 09/11/23
Kim Paul CFO and Treasurer CFO and Treasurer Aug 28 Sell 33.6243 10,299 346,297 215,553 08/30/23
Xie Jian President and COO President and COO Jun 02 Sell 40.2961 1,433 57,744 425,794 06/06/23
Kim Paul CFO and Treasurer CFO and Treasurer Jun 02 Sell 40.2961 1,403 56,535 228,890 06/06/23
Gao Hanlin Chief Scientific Off.. Chief Scientific Officer Jun 02 Sell 40.2961 1,000 40,296 914,391 06/06/23
Xie Jian President and COO President and COO Nov 30 Sell 34.3932 685 23,559 430,074 12/02/22
KIM PAUL CFO and Treasurer CFO and Treasurer Sep 06 Sell 41.3942 662 27,403 149,507 09/08/22
Xie Jian President and COO President and COO Aug 30 Sell 44.183 675 29,824 309,729 09/01/22
Xie Jian President and COO President and COO Aug 17 Sell 48.8945 1,414 69,137 310,404 08/19/22
KIM PAUL CFO and Treasurer CFO and Treasurer Aug 17 Sell 48.8945 1,945 95,100 150,169 08/19/22
Gao Hanlin Chief Scientific Off.. Chief Scientific Officer Aug 17 Sell 48.8945 370 18,091 855,280 08/19/22
KIM PAUL CFO and Treasurer CFO and Treasurer Jun 02 Sell 55.102 415 22,867 153,162 06/06/22
KIM PAUL CFO and Treasurer CFO and Treasurer Mar 03 Sell 56.3081 454 25,564 155,574 03/04/22
KIM PAUL CFO and Treasurer CFO and Treasurer Nov 16 Sell 96.16 2,169 208,571 131,826 11/18/21
KIM PAUL CFO and Treasurer CFO and Treasurer Jun 04 Sell 72.8 1,250 91,000 142,188 06/04/21
KIM PAUL CFO and Treasurer CFO and Treasurer May 27 Sell 72.92 28,358 2,067,865 143,438 05/27/21
Xie Jian Chief Operating Offi.. Chief Operating Officer May 20 Sell 72.6 1,931 140,191 340,041 05/20/21